Shorter DAPT Tested Following CABG - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Shorter DAPT Tested Following CABG

TOP-CABG compared 3 months vs 12 months of ticagrelor plus aspirin following bypass surgery.

  • By

  • Kathryn Wighton

  • June 8, 2026

  • 6 min

Share

Clinical Scorecard: Shorter DAPT Tested Following CABG

At a Glance

CategoryDetail
Condition
Key MechanismsTicagrelor-based dual antiplatelet therapy (DAPT) for reducing SVG occlusion and bleeding risk.
Target Population
Care Setting

Key Highlights

  • Emphasize the clinical relevance of the noninferiority findings for SVG occlusion.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Monitor for SVG occlusion and bleeding events within 1 year, including specific imaging techniques.

      Risks

        Patient & Prescribing Data

        Detail patient selection criteria for the 3-month DAPT strategy.

        Clinical Best Practices

        • Include a note on excluding patients unable to tolerate early postoperative DAPT.

        Related Resources & Content

        Original Source(s)

        Shorter DAPT Tested Following CABG

        • by Kathryn Wighton

        • June 8, 2026

        Related Content

        Medical Oddities: The ghost that haunted a heart

        From haunted hearts to toxic treats, medicine has a few Halloween tricks up its sleeve.

        Case report: Additional Imaging Supports TAPVR Care

        A case report shows that advanced cardiac CT and MRI imaging can improve surgical planning and reintervention for patients with infradiaphragmatic total anomalous pulmonary venous return (TAPVR). See what Sebastián Quiñones-Carrasquillo, MD, and co-authors Todd Nowlen, MD and Daniel Velez, MD, recommend for using these advanced diagnostic imaging modalities.

        • by

        • August 12, 2026

        • 6 min
        Tricuspid regurgitation thresholds reassessed

        The proposed framework classified 30% of patients as high or extreme risk, compared with 12% classified as having severe or greater tricuspid regurgitation under established grading schemes.